---
trial_id: 636
discovery_date: 2022-04-15 12:12:53.644571
date: 2022-04-15 12:12:53.644571
title: "Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen (Relapsing-remitting Multiple Sclerosis and Active Secondary Progressive Multiple Sclerosis)"
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04940065'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
